Myelomastocytic leukemia versus mast cell leukemia versus systemic mastocytosis associated with acute myeloid leukemia: A diagnostic challenge

被引：40

作者：

Arredondo, Angela R.

Gotlib, Jason ^{[2
]}

Shier, Luke ^{[3
]}

Medeiros, Bruno ^{[2
]}

Wong, Kathleen ^{[3
]}

Cherry, Athena

Corless, Christopher ^{[4
]}

Arber, Daniel A.

Valent, Peter ^{[5
]}

George, Tracy I. ^{[1
]}

机构：

[1] Stanford Univ, Med Ctr, Sch Med, Dept Pathol, Stanford, CA 94305 USA

[2] Stanford Univ, Sch Med, Dept Med, Div Hematol, Stanford, CA 94305 USA

[3] Univ Alberta Hosp, Dept Lab Med & Pathol, Edmonton, AB T6G 2R7, Canada

[4] Oregon Hlth & Sci Univ, Dept Pathol, Portland, OR 97201 USA

[5] Med Univ Vienna, Dept Internal Med 1, Div Hematol, Vienna, Austria

来源：

AMERICAN JOURNAL OF HEMATOLOGY | 2010年 / 85卷 / 08期

关键词：

KIT MUTATION; T(8/21); D816V; CLASSIFICATION; DELINEATION; DASATINIB; CRITERIA; DISEASES; PATIENT; ASP-816;

D O I：

10.1002/ajh.21713

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：600 / 606

页数：7

共 29 条

[1]

[Anonymous], WHO CLASSIFICATION T

[2] Acute myeloid leukaemia with t(8;21) associated with ''occult'' mastocytosis. Report of an unusual case and review of the literature [J].

Bernd, HW ;

Sotlar, K ;

Lorenzen, J ;

Osieka, R ;

Fabry, U ;

Valent, P ;

Horny, HP .

JOURNAL OF CLINICAL PATHOLOGY, 2004, 57 (03) :324-328

[3] Allele-specific polymerase chain reaction for the imatinib-resistant KIT D816V and D816F mutations in mastocytosis and acute myelogenous leukemia [J].

Corless, Christopher L. ;

Harrell, Patina ;

Lacouture, Mario ;

Bainbridge, Troy ;

Le, Claudia ;

Gatter, Ken ;

White, Clifton, Jr. ;

Granter, Scott ;

Heinrich, Michael C. .

JOURNAL OF MOLECULAR DIAGNOSTICS, 2006, 8 (05) :604-612

[4] Molecular genetics of acute myeloid leukaemia [J].

Dash, A ;

Gilliland, DG .

BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2001, 14 (01) :49-64

[5] Systemic mastocytosis associated with acute myeloid leukemia:: Case report and implications for disease pathogenesis [J].

Escribano, L ;

García-Montero, A ;

Núñez-López, R ;

López-Jiménez, J ;

Almeida, J ;

Prados, A ;

Orfao, A .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2004, 114 (01) :28-33

[6] Activity of the tyrosine kinase inhibitor PKC412 in a patient with mast cell leukemia with the D816V KIT mutation [J].

Gotlib, J ;

Berubé, C ;

Growney, JD ;

Chen, CC ;

George, TI ;

Williams, C ;

Kajiguchi, T ;

Ruan, J ;

Lilleberg, SL ;

Durocher, JA ;

Lichy, JH ;

Wang, YF ;

Cohen, PS ;

Arber, DA ;

Heinrich, MC ;

Neckers, L ;

Galli, SJ ;

Gilliland, DG ;

Coutré, SE .

BLOOD, 2005, 106 (08) :2865-2870

[7] The KIT tyrosine kinase inhibitor midostaurine (PKC412) exhibits a high response rate in aggressive systemic mastocytosis (ASM): Interim results of a phase II trial [J].

Gotlib, Jason ;

George, Tracy I. ;

Corless, Chris ;

Linder, Andrea ;

Ruddell, Alisa ;

Akin, Cem ;

DeAngelo, Daniel J. ;

Kepten, Ilana ;

Lanza, Carlo ;

Heinemann, Heidnan ;

Yin, Ophelia ;

Gallagher, Neil ;

Graubert, Tim .

BLOOD, 2007, 110 (11) :1035A-1035A

[8] Mastocytosis: State of the art [J].

Horny, Hans-Peter ;

Sotlar, Karl ;

Valent, Peter .

PATHOBIOLOGY, 2007, 74 (02) :121-132

[9] The origin of neoplastic mast cells in systemic mastocytosis with AML1/ETO-positive acute myeloid leukemia [J].

Nagai, Surnimasa ;

Ichikawa, Motoshi ;

Takahashi, Tsuyoshi ;

Sato, Hiroyuki ;

Yokota, Hiromitsu ;

Shima, Kurni ;

Izutsu, Koji ;

Hangaishi, Akira ;

Kanda, Yoshinobu ;

Motokura, Toru ;

Chiba, Shigeru ;

Yatomi, Yutaka ;

Kurokawa, Mineo .

EXPERIMENTAL HEMATOLOGY, 2007, 35 (11) :1747-1752

[10] Aleukemic mast cell leukemia with abnormal immunophenotype and c-kit mutation D816V [J].

Noack, F ;

Sotlar, K ;

Notter, M ;

Thiel, E ;

Valent, P ;

Horny, HP .

LEUKEMIA & LYMPHOMA, 2004, 45 (11) :2295-2302

← 1 2 3 →